NCT03114163View on ClinicalTrials.gov

Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy

CompletedOBSERVATIONAL
Enrollment

485

Participants

Timeline

Start Date

May 12, 2017

Primary Completion Date

April 28, 2025

Study Completion Date

April 28, 2025

Conditions
Head and Neck Cancer
Trial Locations (1)

04103

Local Institution - 0001, Leipzig

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03114163 - Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy | Biotech Hunter | Biotech Hunter